Starlake Bioscience Co Inc Zhaoqing Guangdong - Asset Resilience Ratio

Latest as of March 2026: 0.29%

Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has an Asset Resilience Ratio of 0.29% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Starlake Bioscience Co Inc Zhaoqing Guan current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥50.78 Million

≈ $7.43 Million USD Cash + Short-term Investments

Total Assets

CN¥17.39 Billion

≈ $2.54 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1995–2025)

This chart shows how Starlake Bioscience Co Inc Zhaoqing Guangdong's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Starlake Bioscience Co Inc Zhaoqing Guan's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Starlake Bioscience Co Inc Zhaoqing Guangdong's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600866 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥50.78 Million	0.29%
Total Liquid Assets	CN¥50.78 Million	0.29%

Asset Resilience Insights

Limited Liquidity: Starlake Bioscience Co Inc Zhaoqing Guangdong maintains only 0.29% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Starlake Bioscience Co Inc Zhaoqing Guangdong Industry Peers by Asset Resilience Ratio

Compare Starlake Bioscience Co Inc Zhaoqing Guangdong's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Abivax SA PA:ABVX	Biotechnology	2.58%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Pulike Biological Engineering SHG:603566	Biotechnology	17.82%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	14.00%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Upstream Bio, Inc. NASDAQ:UPB	Biotechnology	64.70%

Annual Asset Resilience Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong (1995–2025)

The table below shows the annual Asset Resilience Ratio data for Starlake Bioscience Co Inc Zhaoqing Guangdong.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	CN¥462.07K ≈ $67.62K	CN¥17.24 Billion ≈ $2.52 Billion	-1.04pp
2024-12-31	1.04%	CN¥151.05 Million ≈ $22.10 Million	CN¥14.55 Billion ≈ $2.13 Billion	+0.99pp
2023-12-31	0.04%	CN¥6.41 Million ≈ $937.75K	CN¥14.38 Billion ≈ $2.10 Billion	-1.87pp
2022-12-31	1.91%	CN¥306.16 Million ≈ $44.80 Million	CN¥16.00 Billion ≈ $2.34 Billion	+1.75pp
2021-12-31	0.17%	CN¥4.12 Million ≈ $602.47K	CN¥2.47 Billion ≈ $361.93 Million	-7.14pp
2016-12-31	7.31%	CN¥125.00 Million ≈ $18.29 Million	CN¥1.71 Billion ≈ $250.27 Million	+6.94pp
2015-12-31	0.37%	CN¥6.89 Million ≈ $1.01 Million	CN¥1.84 Billion ≈ $269.83 Million	+0.35pp
2014-12-31	0.02%	CN¥541.56K ≈ $79.25K	CN¥2.26 Billion ≈ $330.05 Million	-0.63pp
2013-12-31	0.65%	CN¥16.96 Million ≈ $2.48 Million	CN¥2.60 Billion ≈ $381.01 Million	+0.64pp
2012-12-31	0.01%	CN¥381.68K ≈ $55.85K	CN¥3.33 Billion ≈ $487.67 Million	-0.01pp
2011-12-31	0.02%	CN¥774.46K ≈ $113.33K	CN¥3.42 Billion ≈ $500.81 Million	+0.02pp
2009-12-31	0.00%	CN¥35.50K ≈ $5.19K	CN¥1.50 Billion ≈ $219.15 Million	-0.02pp
2005-12-31	0.02%	CN¥289.32K ≈ $42.34K	CN¥1.36 Billion ≈ $199.66 Million	+0.00pp
2004-12-31	0.02%	CN¥265.71K ≈ $38.88K	CN¥1.30 Billion ≈ $190.85 Million	-0.04pp
2003-12-31	0.06%	CN¥700.24K ≈ $102.47K	CN¥1.17 Billion ≈ $171.41 Million	-1.50pp
2002-12-31	1.56%	CN¥15.93 Million ≈ $2.33 Million	CN¥1.02 Billion ≈ $149.82 Million	-1.00pp
2001-12-31	2.55%	CN¥25.59 Million ≈ $3.74 Million	CN¥1.00 Billion ≈ $146.56 Million	+2.50pp
1999-12-31	0.06%	CN¥500.00K ≈ $73.17K	CN¥847.38 Million ≈ $124.00 Million	+0.05pp
1997-12-31	0.01%	CN¥26.00K ≈ $3.80K	CN¥510.92 Million ≈ $74.76 Million	0.00pp
1996-12-31	0.01%	CN¥26.00K ≈ $3.80K	CN¥385.33 Million ≈ $56.39 Million	-0.01pp
1995-12-31	0.01%	CN¥51.53K ≈ $7.54K	CN¥359.32 Million ≈ $52.58 Million	--

pp = percentage points

About Starlake Bioscience Co Inc Zhaoqing Guangdong

SHG:600866 China Biotechnology

Market Cap

$1.02 Billion

CN¥6.98 Billion CNY

Market Cap Rank

#8896 Global

#2183 in China

Share Price

CN¥4.20

Change (1 day)

-0.71%

52-Week Range

CN¥4.06 - CN¥8.13

All Time High

CN¥9.46